These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1581440)

  • 41. The structure of phobias in panic disorder.
    Argyle N; Solyom C; Solyom L
    Br J Psychiatry; 1991 Sep; 159():378-82. PubMed ID: 1958949
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diurnal rhythms and symptom severity in panic disorder. A preliminary study of 24-hour changes in panic attacks, generalised anxiety, and avoidance behaviour.
    Geraci MF; Uhde TW
    Br J Psychiatry; 1992 Oct; 161():512-6. PubMed ID: 1393338
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cognitive style, alprazolam plasma levels, and treatment response in panic disorder.
    Uhlenhuth EH; Starcevic V; Qualls C; Antal EJ; Matuzas W; Javaid JI; Barnhill J
    Depress Anxiety; 2008; 25(8):E18-26. PubMed ID: 17960759
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Suicide attempts, panic disorder, and depression: an update.
    Weissman MM
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():174A-175A. PubMed ID: 1498799
    [No Abstract]   [Full Text] [Related]  

  • 45. Suicidal ideation and suicide attempts among patients with panic disorder: a survey of two outpatient clinics.
    Friedman S; Jones JC; Chernen L; Barlow DH
    Am J Psychiatry; 1992 May; 149(5):680-5. PubMed ID: 1575260
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Controlled trial of alprazolam supplementation during imipramine treatment of panic disorder.
    Woods SW; Nagy LM; Koleszar AS; Krystal JH; Heninger GR; Charney DS
    J Clin Psychopharmacol; 1992 Feb; 12(1):32-8. PubMed ID: 1552038
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo.
    Keller MB; Lavori PW; Goldenberg IM; Baker LA; Pollack MH; Sachs GS; Rosenbaum JF; Deltito JA; Leon A; Shear K
    J Affect Disord; 1993 May; 28(1):27-38. PubMed ID: 8326078
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Suicidal behavior in patients with panic disorder: retrospective and prospective data.
    Warshaw MG; Massion AO; Peterson LG; Pratt LA; Keller MB
    J Affect Disord; 1995 Jun; 34(3):235-47. PubMed ID: 7560552
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antidepressant treatment is associated with a reduction in suicidal ideation and suicide attempts.
    Mulder RT; Joyce PR; Frampton CM; Luty SE
    Acta Psychiatr Scand; 2008 Aug; 118(2):116-22. PubMed ID: 18384467
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Panic attacks and panic disorder. Checklist for the diagnosis].
    Boerner RJ
    MMW Fortschr Med; 2003 May; 145 Suppl 2():9-12. PubMed ID: 14579476
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Subtyping panic disorder by major depression and avoidance behaviour and the response to active treatment.
    Maier W; Rosenberg R; Argyle N; Buller R; Roth M; Brandon S; Benkert O
    Eur Arch Psychiatry Clin Neurosci; 1991; 241(1):22-30. PubMed ID: 1832302
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The efficacy and safety of alprazolam versus other benzodiazepines in the treatment of panic disorder.
    Moylan S; Staples J; Ward SA; Rogerson J; Stein DJ; Berk M
    J Clin Psychopharmacol; 2011 Oct; 31(5):647-52. PubMed ID: 21869686
    [TBL] [Abstract][Full Text] [Related]  

  • 53. "Panic-like" symptomatology in schizophrenic and schizoaffective patients with postpsychotic depression: observations and implications.
    Cutler JL; Siris SG
    Compr Psychiatry; 1991; 32(6):465-73. PubMed ID: 1778073
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Predictors of response to alprazolam and placebo in patients with panic disorder.
    Woodman CL; Noyes R; Ballenger JC; Lydiard RB; Sievers G; Mihalko D
    J Affect Disord; 1994 Jan; 30(1):5-13. PubMed ID: 8151049
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Rethink the panic disorder].
    Amami O; Aloulou J; Siala M; Aribi L
    Encephale; 2010 Apr; 36(2):100-4. PubMed ID: 20434625
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alprazolam premedication and 35% carbon dioxide vulnerability in panic patients.
    Pols H; Verburg K; Hauzer R; Meijer J; Griez E
    Biol Psychiatry; 1996 Nov; 40(9):913-7. PubMed ID: 8896779
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Time-related predictors of suicide in major affective disorder.
    Fawcett J; Scheftner WA; Fogg L; Clark DC; Young MA; Hedeker D; Gibbons R
    Am J Psychiatry; 1990 Sep; 147(9):1189-94. PubMed ID: 2104515
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Treatment of panic disorder.
    Cassano GB; Toni C; Musetti L
    Adv Biochem Psychopharmacol; 1992; 47():449-60. PubMed ID: 1509926
    [No Abstract]   [Full Text] [Related]  

  • 59. Nonclinical panic and suicidality: prevalence and psychopathology.
    Woodruff-Borden J; Stanley MA; Lister SC; Tabacchi MR
    Behav Res Ther; 1997 Feb; 35(2):109-16. PubMed ID: 9046674
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lifetime comorbidity of panic attacks and major depression in a population-based study. Symptom profiles.
    Andrade L; Eaton WW; Chilcoat H
    Br J Psychiatry; 1994 Sep; 165(3):363-9. PubMed ID: 7994507
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.